---
title: "Reviews — chondroitin sulfate - Flapen"
canonical_url: "https://flapen.com/research/us/health-household/chondroitin-sulfate/reviews"
last_updated: "2026-08-05T23:47:24.195Z"
locale: en
meta:
  description: "Niche score 51/100 · $137K/yr market · 40K searches/yr · $24.50 avg price. Soft demand (+2.6% this quarter) keeps it on the watch list. Data updated Jul 2026."
  "og:description": "Niche score 51/100 · $137K/yr market · 40K searches/yr · $24.50 avg price. Soft demand (+2.6% this quarter) keeps it on the watch list. Data updated Jul 2026."
  "og:title": "Reviews — chondroitin sulfate - Flapen"
---

# **chondroitin sulfate**

**Worth a look**

Shows low returns (0.0%), but soft demand (+2.6% this quarter) keeps it on the watch list.

Market size 30Growth 28Conversion 96Competition 28Returns 100Price range 89Avg price 95Brand share 46Review moat 30Quality gap 35

**Returns**

**Incredible****0.0%**

return rate — above 5% kills the launch gate

**Conversion**

**Incredible****14.0%**

search→purchase rate — share of searches ending in a sale

**Avg price**

**Incredible****$24.50**

avg listing price — sweet spot $15–$100

**Price range**

**Great****$9.92–$72.77**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Brand share**

**Okay****78%**

top-5 brand share — brands hold most of the demand

**Quality gap**

**Okay****4.5★**

avg incumbent rating — lower means beatable quality

**Market size**

**Okay****$137K**

$137K/yr · 40K searches

**Review moat**

**Okay****3,535.71**

avg incumbent reviews — the moat a new listing must climb

**Growth**

**Okay****+2.6%**

90-day search growth — must beat 0% to launch

**Competition**

**Okay****68%**

top-5 click share — leaders hold, buyers still browse

**Signals**[** Low Review Barrier**](https://flapen.com/research/niches?market=us&signal=low_review_barrier "Top brand's reviews < 500")

## Reviews